Printer Friendly

GENSIA EUROPE LTD. APPOINTS STEWART SIDDALL TO BOARD OF DIRECTORS

 SAN DIEGO, July 14 /PRNewswire/ -- Gensia Inc. (NASDAQ: GNSA) today announced that Stewart Siddall, president of the Association of the British Pharmaceutical Industry (ABPI) has been appointed to the board of directors of Gensia Europe Ltd., a wholly owned subsidiary of Gensia Inc. Gensia Europe is responsible for the organization of clinical trials and regulatory filings and later marketing and sales of Gensia's products throughout Europe.
 Siddall has 30 years experience in the pharmaceutical industry working in senior management positions with SmithKline and French Laboratories and SmithKline Beecham in Europe, Asia and the United States. Currently, Siddall is chairman of UK Pharmaceuticals and senior vice president for Public Industry Affairs, SmithKline Beecham. Siddall, a recognized authority on European pharmaceutical issues, is also a member of the Executive Committee of the European Federation of Pharmaceutical Industries Associations (EFPIA) and has significant interactions with the U.K. Ministry of Health and other similar authorities in Europe.
 David F. Hale, chairman, president and chief executive officer, said, "We are pleased to have such a distinguished member of the pharmaceutical community as a board member of Gensia Europe and believe his experience and understanding of the pharmaceutical market in Europe will be very valuable to Gensia in successfully establishing its operations in Europe."
 Gensia is a San Diego-based biopharmaceutical company formed to discover, develop, manufacture and market novel pharmaceutical products for the treatment and diagnosis of human diseases.
 -0- 7/14/93
 /CONTACT: Elizabeth A. Gard of Gensia Pharmaceuticals, 619-546-8300/
 (GNSA)


CO: Gensia Pharmaceuticals Inc.; Gensia Europe Ltd. ST: California IN: MTC SU: PER

JB-EH -- SD003 -- 1405 07/14/93 12:17 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 14, 1993
Words:269
Previous Article:STUTZ RESIGNS FROM HOMEFED TO HEAD INVESTOR GROUP TO BUY THE THRIFT
Next Article:MK TO BUILD HIGH-TECHNOLOGY BRAKE PLANT FOR KELSEY-HAYES IN THE NETHERLANDS
Topics:


Related Articles
NICHOLAS YEO JOINS GENSIA EUROPE LTD. AS DIRECTOR OF MARKETING - EUROPE
GENSIA APPOINTS MARTHA HOUGH VICE PRESIDENT OF PLANNING & ADMINISTRATION
GENSIA HIRES NEW RESEARCH DIRECTORS IN CENTRAL NERVOUS SYSTEM PHARMACOLOGY AND IMMUNOLOGY
GENSIA APPOINTS HERBERT CONRAD TO BOARD OF DIRECTORS
ARAMED NAMES NEW MEMBERS OF BOARD OF DIRECTORS
Gensia Announces Strategic Combination to Form International Specialty Pharmaceutical Company
Gensia Completes Acquisition of Three Specialty Pharmaceutical Companies
Gensia Sicor Appoints Sanofi Winthrop Exclusive Distributor for Brevibloc In U.K. and Ireland
Gensia Sicor Announces Management Appointments

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters